CD8A and neoplasm: Interestingly, the ability of Folfox to synergize with anti-PD-1 therapy was directly associated with the Folfox-driven induction of IFNγ-producing CD8 T cells as well as of enhanced PD-L1 expression on tumor cells in vivo.